ORNBV Orion Oyj
80.85EUR+0.06%Mkt Cap: 12.34B $P/E: 19.391d ago
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharm…
Industry Peers
Drug Manufacturers - General$1.02TUSDP/E 38.4
$609.54BUSDP/E 29.3
$469.63BUSDP/E 75.1
$325.55BUSDP/E 23.4
$344.27BUSDP/E 110.7
$267.87BUSDP/E 21.3
$252.68BUSDP/E 22.2
$260.71BUSDP/E 25.2
$242.76BUSDP/E 23.4
$231.42BUSDP/E 24.9
$217.86BUSDP/E 25.0
$198.31BUSDP/E 23.6
$179.33BUSD
$165.76BUSDP/E 9.2
$156.23BUSDP/E 36.1
$120.13BUSDP/E 13.0
$94.67BUSDP/E 20.8
$91.14BUSDP/E 21.5
$93.26BUSDP/E 14.7
$76.61BUSDP/E 14.9
| Headline | Source | Time |
|---|---|---|
Older | ||
 Orion Oyj (HLSE:ORNBV) Has Investors Asking Questions Orion Oyj (HLSE:ORNBV) has drawn attention after recent share price moves, with the stock last closing at €82.95. Investors are weighing that level against its historical returns and current valuation signals. Recent trading has built on earlier gains, with a 30-day share price return of 3.56% contributing to an 18.50% move over 90 days and a 31.04% year to date rise. Orion Oyj’s 1-year and 5-year total shareholder returns of 33.49% and 184.79% respectively show how recent momentum fits into... | ||